Working with Rephine enabled us to harmonise and
digitalise our global quality systems more efficiently than
we thought possible. Their expertise helped us navigate the
complexity of implementation while ensuring readiness for
inspections from day one.
Client Testimonial
About this Case Study
A leading global API manufacturer, operating multiple sites worldwide, faced significant challenges in managing and harmonising its quality processes. Manual, fragmented systems made it difficult to ensure oversight, consistency, and regulatory readiness across the organisation.
Rephine partnered with the client to implement a fully digital Quality Management System (QMS), supported by Document Management (DMS) and Training Management (TMS) solutions. Over a 9–12 month programme, the solution delivered scalable, standardised, and inspection-ready quality processes across global sites.
Key outcomes included:
- Harmonisation and standardisation of global quality processes
- Successful regulatory inspections with positive outcomes
- Reduced training overhead and faster onboarding through centralised TMS
- Improved visibility of quality indicators and decision-making dashboards
- Reduction in the total cost of ownership of quality systems
✅ Download the full case study to discover:
- How Rephine delivered a phased QMS, DMS, and TMS implementation across multiple sites
- The validation and post-go-live strategies that ensured inspection readiness
- How measurable efficiency gains and compliance outcomes were achieved
Result: A streamlined, compliant, and future-ready digital quality system supporting long-term growth.
Download the Case Study
View other our other resources and company news
Case Study From Cosmetics to OTC: Full FDA GMP Compliance Achieved in 12 Months
A global cosmetics manufacturer wanted to enter the OTC pharmaceutical market but had zero GMP experience. In 12 months, their Spanish production site achieved full ...
Read More
Article GDP Transport Validation: A Practical Guide for Pharmaceutical Companies
Transport validation is a regulatory requirement under EU GMP Annex 15, yet many pharmaceutical companies still struggle with route selection and risk assessment. This guide ...
Read More
Article Veterinary GMP in Europe: New Dedicated Framework & VICH GL60 Guide
The EU veterinary sector enters a new era on 16 July 2026. Dedicated GMP regulations replace EudraLex Volume 4 for veterinary products. Learn what changes ...
Read More
Article MDR & IVDR Compliance: A Strategic Approach for MedTech
Regulatory compliance under MDR and IVDR has moved beyond documentation to become a strategic discipline that shapes every stage of a medical device's lifecycle. This ...
Read More
Medical Device MDR & IVDR Compliance as a Business Outcome
Rephine's 2026 White Paper on MDR & IVDR compliance: strategic guidance for MedTech companies to reduce regulatory risk, avoid delays, and reach the EU market ...
Read More
Case Study Full GMP Internal Audit Program Executed On Time
A pharmaceutical manufacturer needed to complete their annual EU GMP internal audit cycle across 11 departments, without the internal capacity to do it. See how ...
Read More
QMS From local to global: scaling your QMS for UK–EU operations
Learn how UK life sciences companies can scale their quality management system into EU markets without losing compliance, visibility, or operational control.
Read More
QMS Scale Your Quality System from UK to EU Without Losing Control
Learn how UK life sciences companies can scale their quality management system into EU markets without losing compliance, visibility, or operational control.
Read More
Article Pharmaceutical Equipment Qualification & Control System Validation
Qualifying process equipment and control systems is fundamental to GMP compliance. This guide breaks down how to define user requirements, apply risk-based testing, and maintain ...
Read More
